Dec 12, 2024, 09:02
Dmitriy Zamarin: Innate and adaptive immune activation in cancer cells deficient in SMARCA4
Dmitriy Zamarin, Section Head of Gynecologic Medical Oncology at Icahn School of Medicine at Mount Sinai, shared on X:
“Check out our new story!
Mechanisms of innate and adaptive immune activation in cancer cells deficient in SMARCA4.
Thank you to the multiple collaborators that made it possible.”
Authors: Melica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, Ana Leda F. Longhini, Andrea Gazzo, Siyu Sun, Richard P. Koche, Rui Qu, Laura Rosenberg, Pierre-Jacques Hamard, Yonina Bykov, Hunter Green, Laxmi Gusain, Katherine B. Chiappinelli, Melih Arda Ozsoy, M. Herman Chui, Thais Basili, Rui Gardner, Sven Walderich, Elisa Destanchina, Benjamin Greenbaum, Mithat Gönen, Nicolas Vabret, Britta Weigelt, and Dmitriy Zamarin.
Ana Leda F. Longhini
Andrea Gazzo
Benjamin Greenbaum
Britta Weigelt
cancer
Dmitriy Zamarin
Elisa Destanchina
Higinio Dopeso
Hunter Green
Icahn School of Medicine
immune activation
Katherine B. Chiappinelli
Laura Rosenberg
Laxmi Gusain
M. Herman Chui
Melica Nourmoussavi Brodeur
Melih Arda Ozsoy
Mithat Gönen
Nicolas Vabret
OncoDaily
Oncology
Pierre-Jacques Hamard
Richard P. Koche
Rui Gardner
Rui Qu
Siyu Sun
SMARCA4
Sven Walderich
Thais Basili
Yingjie Zhu
Yonina Bykov
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 12, 2024, 08:26
Dec 12, 2024, 08:04
Dec 12, 2024, 08:01
Dec 11, 2024, 19:40
Dec 11, 2024, 19:40
Dec 11, 2024, 19:40
Dec 11, 2024, 19:40